Cholinesterase inhibitor, used for the treatment of memory disorders in patients with Alzheimer’s disease and for the treatment of dementia in patients with Alzheimer’s Parkinson.
| DRUG ACTIVE SUBSTANCE | CONTENT | PHARMACEUTICAL FORM | PACKAGING | THERAPEUTICAL CATEGORY |
| Rivastigmine | 2 mg/mL | Oral solution | FL x 50 mL FL x 120 mL |
Cholinesterase inhibitor |